Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anyu Peibo Dose-Finding Study in MDD
NCT02380066Phase 2Completed
- Sponsor
- Shanghai Mental Health Center
- Start
- Mar 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of anyu peibo in major depressive disorder (MDD), sponsored by Shanghai Mental Health Center. Started Mar 2015; status: completed.
02
Drugs
anyu peibo
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02380066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02380066.